Citation: Zhi-Pei Sang, Teng Xue, Qian-Ru Xing, Qi-Yao Zhang, Hong-Song Chen, Xue Wang, Fu-Rong Zhang, Wen-Ling Fu, Wu Dong, Shu-Heng Huang, Yi-You Huang, Hai-Bin Luo. Discovery of α-mangostin derivatives as novel PDE4 inhibitors for the treatment of Alzheimer's disease: An artificial intelligence-driven synergized strategy[J]. Chinese Chemical Letters, ;2026, 37(5): 111318. doi: 10.1016/j.cclet.2025.111318 shu

Discovery of α-mangostin derivatives as novel PDE4 inhibitors for the treatment of Alzheimer's disease: An artificial intelligence-driven synergized strategy

Zhi-Pei Sang ^{a, 1} ,
Teng Xue ^{a, 1} ,
Qian-Ru Xing ^{a, 1} ,
Qi-Yao Zhang ^a ,
Hong-Song Chen ^b ,
Xue Wang ^a ,
Fu-Rong Zhang ^a ,
Wen-Ling Fu ^a ,
Wu Dong ^b ,
Shu-Heng Huang ^{a, *,} ,
Yi-You Huang ^{a, *,} ,
Hai-Bin Luo ^{a, c, *,}

a.
Key Laboratory of Tropical Biological Resources of Ministry of Education and Hainan Engineering Research Center for Drug Screening and Evaluation, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China
b.
College of Animal Science and Technology. Inner Mongolia Minzu University, Tongliao 028000, China
c.
Song Li's Academician Workstation of Hainan University (School of Pharmaceutical Sciences), Yazhou Bay, Sanya 572000, China

shhuang@hainanu.edu.cn

hyyou@hainanu.edu.cn

hbluo@hainanu.edu.cn

Received Date: 6 February 2025
Revised Date: 13 May 2025
Accepted Date: 14 May 2025
Available Online: 16 May 2025

Figures(4)

Alzheimer's disease (AD) is a chronic, progressive neurodegenerative disorder with no effective therapeutic agents currently available. Inhibiting phosphodiesterase 4 (PDE4) has emerged as a promising strategy for AD treatment. In this study, we employed a synergistic approach combining generative recurrent neural network (RNN)-driven combinatorial compound design, virtual screening, and structure-activity relationship (SAR) analysis to discover novel PDE4 inhibitors. Utilizing α-mangostin as a hit compound (half maximal inhibitory concentration (IC₅₀) = 1.31 µmol/L), we identified a novel PDE4 inhibitor, 13d (IC₅₀ = 72.8 nmol/L) with moderate liver microsomal stability (rat liver microsomes (RLM), t_1/2 = 32.4 min). In vitro activity results indicated that 13d exhibited favorable anti-inflammatory effects and promising neuroprotective activity. In vivo experiments demonstrated that 13d significantly improved AlCl₃-induced zebrafish AD model by inhibiting PDE4 and reducing inflammatory cytokine. Further, 13d significantly alleviated AlCl₃/d-galactose-induced AD mouse model. These findings highlight the potent PDE4 inhibitor 13d with promising anti-AD activity, underscoring the potential of artificial intelligence-driven drug discovery for novel therapeutic agents for AD.
- Alzheimer's disease,
- Generative recurrent neural network,
- α-Mangostin,
- PDE4 inhibitor,
- In vivo study
1. [1]
  R. Hodson, Nature 559 (2018) S1–S2. doi: 10.1038/d41586-018-05717-6
2. [2]
  S. Long, C. Benoist, W. Weidner, World Alzheimer Report 2023, Alzheimer's Disease International, London, 2023.
3. [3]
  J. Zhang, Y. Zhang, J. Wang, et al., Signal Transduct. Target. Ther. 9 (2024) 211.
4. [4]
  I. Terao, W. Kodama, Ageing Res. Rev. 94 (2024) 102203. doi: 10.1016/j.arr.2024.102203
5. [5]
  S. Gauthier, Drugs Aging 18 (2001) 853–862. doi: 10.2165/00002512-200118110-00006
6. [6]
  Y. Chen, M. Lai, M. Tao, Medicine 103 (2024) e37799. doi: 10.1097/md.0000000000037799
7. [7]
  R.A. Hansen, G. Gartlehner, A.P. Webb, et al., Clin. Interv. Aging 3 (2008) 211–225.
8. [8]
  J. Prickaerts, P.R.A. Heckman, A. Blokland, Expert. Opin. Investig. Drugs 26 (2017) 1033–1048. doi: 10.1080/13543784.2017.1364360
9. [9]
  Y. Wu, Z. Li, Y.Y. Huang, et al., J. Med. Chem. 61 (2018) 5467–5483. doi: 10.1021/acs.jmedchem.7b01370
10. [10]
  Z. Donders, I.J. Skorupska, E. Willems, et al., Biomed. Pharmacother. 177 (2024) 117009. doi: 10.1016/j.biopha.2024.117009
11. [11]
  H. Wang, F.F. Zhang, Y. Xu, et al., Int. J. Neuropsychopharmacol. 23 (2020) 700–711. doi: 10.1093/ijnp/pyaa048
12. [12]
  C. Wang, X.M. Yang, Y.Y. Zhuo, et al., Int. J. Neuropsychopharmacol. 15 (2012) 749–766. doi: 10.1017/S1461145711000836
13. [13]
  H. Guo, Y. Cheng, C. Wang, et al., Neuropharmacology 116 (2017) 260–269. doi: 10.1016/j.neuropharm.2017.01.004
14. [14]
  N. Possemis, F. Verhey, J. Prickaerts, et al., Trials 25 (2024) 162. doi: 10.1186/s13063-024-08001-3
15. [15]
  M.A. Van Duinen, A. Sambeth, P.R.A. Heckman, et al., Neuropharmacology 131 (2018) 31–38.
16. [16]
  T. Chavan, A. Muth. Future Med. Chem. 13 (2021) 1679–1694. doi: 10.4155/fmc-2021-0146
17. [17]
  G. Chen, Y. Li, W. Wang, et al., Expert. Opin. Ther. Pat. 28 (2018) 415–427. doi: 10.1080/13543776.2018.1455829
18. [18]
  A. Yang, C. Liu, J. Wu, et al., Eur. J. Pharmacol. 897 (2021) 173950.
19. [19]
  J. Liang, Y.Y. Huang, Q. Zhou, et al., J. Med. Chem. 63 (2020) 3370–3380. doi: 10.1021/acs.jmedchem.0c00060
20. [20]
  L.S. Franco, B.D.S.M. de Jesus, P.S.M. Pinheiro, et al., Pharmaceuticals 17 (2024) 742. doi: 10.3390/ph17060742
21. [21]
  J.L. Medina-Franco, E. López-López. Expert. Opin. Drug Discov. 19 (2024) 507–510. doi: 10.1080/17460441.2024.2331734
22. [22]
  D. Paul, G. Sanap, S. Shenoy, et al., Drug Discov. Today 26 (2021) 80–93.
23. [23]
  D. Salley, J.S. Manzano, P.J. Kitson, et al., ACS Cent. Sci. 9 (2023) 1525–1537. doi: 10.1021/acscentsci.3c00304
24. [24]
  Z. Chen, Y. Shi, F. Zhong, et al., Chin. Chem. Lett. 36 (2025) 109956. doi: 10.1016/j.cclet.2024.109956
25. [25]
  Q. Zhou, M. Le, Y. Yang, et al., Acta Pharm. Sin. B 13 (2023) 1180–1191.
26. [26]
  Y.Y. Huang, X. Luo, K. Zhang, et al., Chin. Chem. Lett. 36 (2025) 110586.
27. [27]
  E.E. Patton, L.I. Zon, D.M. Langenau. Nat. Rev. Drug Discov. 20 (2021) 611–628. doi: 10.1038/s41573-021-00210-8
28. [28]
  P. Bhattarai, B. Turgutalp, C. Kizil, ACS Chem. Neurosci. 13 (2022) 2939–2941. doi: 10.1021/acschemneuro.2c00583
29. [29]
  A.P. Nadiga, S.K., Krishna, Eur. J. Pharmacol. 965 (2024) 176332.
30. [30]
  R. Chen, X. Li, H. Chen, et al., Eur. J. Med. Chem. 251 (2023) 115253.
31. [31]
  H. Chen, J. Mi, S. Li, et al., J. Enzyme Inhib. Med. Chem. 38 (2023) 2169682.
32. [32]
  Y.H. Chong, Y.H. Suh, Brain Res. 670 (1995) 137–1341.
33. [33]
  A. Tanas, Ö.Ö. Tozlu, T. Gezmiş, et al., Biomed Res. Int. 2022 (2022) 5467498.
34. [34]
  Y. Hu, X. Fang, J. Wang, et al., Neurotoxicology 91 (2022) 60–68.
35. [35]
  T. Vishnumukkala, P.K. Gopalakrishna, B. Karikalan, et al., Bioinformation 20 (2024) 508–514. doi: 10.6026/973206300200508
1. [1]
  Jiajie Gu , Jiaxiang Gu , Lei Yu . Selenium and Alzheimer's disease. Chinese Chemical Letters, 2025, 36(8): 110727-. doi: 10.1016/j.cclet.2024.110727
2. [2]
  Qiyao Zhang , Yuting Li , Qishun Jin , Zhengwei Liu , Hongsong Chen , Jingqi Huang , Taoyi Liu , Xiaojuan Liu , Zhenghuai Tan , Shuheng Huang , Wu Dong , Zhipei Sang . Artificial intelligence-driven development of natural multi-target derivatives with BuChE inhibitory activity for treating Alzheimer’s disease. Chinese Chemical Letters, 2026, 37(1): 110964-. doi: 10.1016/j.cclet.2025.110964
3. [3]
  Weiqun Li , Ming-Jie Dong , Haibing Dai , Shanming Lu , Ran Luo , Jiahui Cao , Fan Zhang , Lin Mei , Jianbo Yu . Application of mitochondrial miRNA-204 nanoprobes in Alzheimer's disease treatment by clearing reactive oxygen species-mediated autophagy. Chinese Chemical Letters, 2025, 36(8): 110614-. doi: 10.1016/j.cclet.2024.110614
4. [4]
  Jiajia Lv , Jie Gao , Hongyu Li , Zeli Yuan , Nan Dong . Rational design of hydroxytricyanopyrrole-based probes with high affinity and rapid visualization for amyloid-β aggregates in vitro and in vivo. Chinese Chemical Letters, 2024, 35(5): 108940-. doi: 10.1016/j.cclet.2023.108940
5. [5]
  Yu-Qi Cao , Ying-Jie Lu , Li Zhang , Jing Zhang , Yin-Long Guo . Vacuum promoted on-tissue derivatization strategy: Unravelling spatial distribution of glycerides on tissue. Chinese Chemical Letters, 2024, 35(12): 109788-. doi: 10.1016/j.cclet.2024.109788
6. [6]
  Le Chen , Hui Wang , Yiyun Cheng . An erucin-anchored polymer with excellent amyloidosis inhibition and direct cell membrane penetration ability for intracellular protein delivery. Chinese Chemical Letters, 2026, 37(4): 111172-. doi: 10.1016/j.cclet.2025.111172
7. [7]
  Yue Cao , Yue Lin , Li Chen , Huimin Niu , Renli Wei , Shuqian Qiu , Anjie Wang , Xiaoai Cao , Xiaofeng Lai , Yongshou Chen , Juanjuan Lin , Shuiliang Wang , Zhenyu Lin , Shenghang Zhang . Screening of glial fibrillary acidic protein specific aptamer and application in the development of fluorescent biosensor based on isothermal amplification strategy. Chinese Chemical Letters, 2026, 37(5): 111616-. doi: 10.1016/j.cclet.2025.111616
8. [8]
  Zhexin Chen , Yuqing Shi , Fang Zhong , Kai Zhang , Furong Zhang , Shenghong Xie , Zhongbin Cheng , Qian Zhou , Yi-You Huang , Hai-Bin Luo . Discovery of amentoflavone as a natural PDE4 inhibitor with anti-fibrotic effects. Chinese Chemical Letters, 2025, 36(4): 109956-. doi: 10.1016/j.cclet.2024.109956
9. [9]
  Xingli Zhang , Peng Xue . Current trends in advanced imaging modalities for the early diagnosis of Alzheimer’s disease. Chinese Chemical Letters, 2026, 37(3): 111628-. doi: 10.1016/j.cclet.2025.111628
10. [10]
  Yi-You Huang , Xiang Luo , Kai Zhang , Yulan Liang , Furong Zhang , Guochao Liao , Shenghong Xie , Pei-Luo Huang , Siyu Hou , Qian Zhou , Yong Zou , Hai-Bin Luo . Structure-based optimization of isoaurostatin as novel PDE4 inhibitors with anti-fibrotic effects. Chinese Chemical Letters, 2025, 36(8): 110586-. doi: 10.1016/j.cclet.2024.110586
11. [11]
  Qing Zhang , Ling Sun , Lingyu Wu , Xue Wang , Liru Chen , Youyou Chen , Yuhang Liu , Wenhui Gu , Donglei Shi , Wenwen Liu , Jian Li , Yi-You Huang , Baoli Li , Hai-Bin Luo . Platycladus orientalis (L.) Franco demonstrates effective anti-psoriasis effects by inhibiting PDE4 with favorable safety profiles. Chinese Chemical Letters, 2025, 36(10): 110795-. doi: 10.1016/j.cclet.2024.110795
12. [12]
  Feihu Wu , Gengwen Chen , Kaitao Lai , Shiqing Zhang , Yingchao Liu , Ruijian Luo , Xiaocong Wang , Pinzhi Cao , Yi Ye , Jiarong Lian , Junle Qu , Zhigang Yang , Xiaojun Peng . Non-specific/specific SERS spectra concatenation for precise bacteria classifications with few samples using a residual neural network. Chinese Chemical Letters, 2025, 36(1): 109884-. doi: 10.1016/j.cclet.2024.109884
13. [13]
  Xiaoxiao Wang , Bolun Wang , Fenfen Ji , Jie Yan , Jiacheng Fang , Doudou Zhang , Ji Xu , Jing Ji , Xinran Hao , Hemi Luan , Yanjun Hong , Shulan Qiu , Min Li , Zhu Yang , Wenlan Liu , Xiaodong Cai , Zongwei Cai . Discovery of plasma biomarkers for Parkinson’s disease diagnoses based on metabolomics and lipidomics. Chinese Chemical Letters, 2024, 35(11): 109653-. doi: 10.1016/j.cclet.2024.109653
14. [14]
  Tao Liu , Xuwei Han , Xueyi Sun , Weijie Zhang , Ke Gao , Runan Min , Yuting Tian , Caixia Yin . An activated fluorescent probe to monitor NO fluctuation in Parkinson’s disease. Chinese Chemical Letters, 2025, 36(3): 110170-. doi: 10.1016/j.cclet.2024.110170
15. [15]
  Weixia Wang , Yongji Zhang , Fei Zhao , Libo Wang , Fanpeng Meng , Shuchao Qin , Jinsheng Zhao . Engineering π-delocalized network in fused-thiophene based polymers/g-C3N4 S-scheme heterojunctions for photocatalytic H2 evolution. Chinese Journal of Structural Chemistry, 2026, 45(3): 100833-100833. doi: 10.1016/j.cjsc.2025.100833
16. [16]
  Yiwen Xu , Chaozheng He , Chenxu Zhao , Ling Fu . Single-atom Ti doping on S-vacancy two-dimensional CrS₂ as a catalyst for ammonia synthesis: A DFT study. Chinese Chemical Letters, 2025, 36(4): 109797-. doi: 10.1016/j.cclet.2024.109797
17. [17]
  Zihong Li , Jie Cheng , Ping Huang , Guoliang Wu , Weiying Lin . Activatable photoacoustic bioprobe for visual detection of aging in vivo. Chinese Chemical Letters, 2024, 35(4): 109153-. doi: 10.1016/j.cclet.2023.109153
18. [18]
  Shihong Wu , Ronghui Zhou , Hang Zhao , Peng Wu . Sonoafterglow luminescence for in vivo deep-tissue imaging. Chinese Chemical Letters, 2024, 35(10): 110026-. doi: 10.1016/j.cclet.2024.110026
19. [19]
  Gongcheng Ma , Qihang Ding , Yuding Zhang , Yue Wang , Jingjing Xiang , Mingle Li , Qi Zhao , Saipeng Huang , Ping Gong , Jong Seung Kim . Palladium-free chemoselective probe for in vivo fluorescence imaging of carbon monoxide. Chinese Chemical Letters, 2024, 35(9): 109293-. doi: 10.1016/j.cclet.2023.109293
20. [20]
  Qian Pang , Fangjun Huo , Yongkang Yue , Caixia Yin . ONOO⁻ and viscosity dual-response fluorescent probe for arthritis imaging in vivo. Chinese Chemical Letters, 2025, 36(9): 110713-. doi: 10.1016/j.cclet.2024.110713

Get Citation

PDF

XML

Metrics

PDF Downloads(0)
Abstract views(7)
HTML views(0)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142